Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2012 Aug 25:10:172.
doi: 10.1186/1477-7819-10-172.

Tea consumption and risk of bladder cancer: a meta-analysis

Jie Qin  1 , Bo Xie, Qiqi Mao, Debo Kong, Yiwei Lin, Xiangyi Zheng
Affiliations
Meta-Analysis

Tea consumption and risk of bladder cancer: a meta-analysis

Jie Qin et al. World J Surg Oncol. .

Abstract

Background: Tea consumption has been reported to be associated with an decreased risk of several types of cancers. However, the results based on epidemiological studies on the association of tea consumption with bladder cancer were inconsistent. This meta-analysis was undertaken to evaluate the relationship between tea consumption and bladder cancer risk.

Methods: Eligible studies were retrieved via both computer searches and review of references. The summary relative risk (RR) with 95% confidence interval (CI) was calculated.

Results: Twenty three studies met the inclusion criteria of the meta-analysis. No association with bladder cancer was observed in either overall tea consumption group (OR =0.94, 95% CI 0.85-1.04) or subgroups stratified by sex, study design, geographical region or tea types.

Conclusions: Our findings did not support that tea consumption was related to the decreased risk of bladder cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A forest plot showing risk estimates from case-control and cohort studies estimating the association between tea consumption and risk for bladder cancer.
Figure 2
Figure 2
Funnel plot of tea consumption and bladder cancer risk.
Figure 3
Figure 3
Forest plots showing the risk estimates from each study and the pooled risk estimates for green tea and black tea.
See this image and copyright information in PMC

References

    1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300. doi: 10.3322/caac.20073. - DOI - PubMed
    1. Lattouf JB. Chemoprevention in bladder cancer: What's new? Can UrolAssoc J. 2009;3:S184–S187. - PMC - PubMed
    1. Busby JE, Kamat AM. Chemoprevention for bladder cancer. J Urol. 2006;176:1914–1920. doi: 10.1016/j.juro.2006.07.004. - DOI - PubMed
    1. Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol. 2002;42:25–54. doi: 10.1146/annurev.pharmtox.42.082101.154309. - DOI - PubMed
    1. Kemberling JK, Hampton JA, Keck RW, Gomez MA, Selman SH. Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate. J Urol. 2003;170:773–776. doi: 10.1097/01.ju.0000081278.64511.96. - DOI - PubMed

Publication types